AMANDA HORACEK: Open Payments
NPI 1104389121 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 36 payments from 12 companies in 2025. Trend: 2023 $1,328 · 2024 $897 · 2025 $842
Food & beverage: $842
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $276 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $145 |
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| GENZYME CORPORATION | 3 | $69 |
| Ardelyx, Inc. | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Madrigal Pharmaceuticals | 1 | $38 |
| QOL Medical, LLC | 2 | $33 |
| Lilly USA, LLC | 1 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
Products named: TREMFYA, AUSTEDO XR, DUPIXENT, ENTYVIO, IBSRELA, REZDIFFRA, Sucraid, OMVOH.
Industry payments across IN — which companies pay providers there.
